User profiles for Rinaldo Pellicano
Pellicano RinaldoSC Gastroenterologia e Epatologia, Azienda Ospedaliero-Universitaria Molinette, Torino Verified email at molinette.piemonte.it Cited by 10645 |
Fecal calprotectin: beyond intestinal organic diseases
…, C Rosso, GM Saracco, M Astegiano, R Pellicano - Panminerva …, 2018 - iris.unito.it
Fecal calprotectin (FC) is a calcium-binding protein with antimicrobic, imunomodulatory and
antiproliferative properties that is mainly found in the cytoplasm of neutrophil granulocytes. …
antiproliferative properties that is mainly found in the cytoplasm of neutrophil granulocytes. …
Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures
…, C De Angelis, E Battaglia, A Musso, R Pellicano… - Gastrointestinal …, 2004 - Elsevier
BACKGROUND: Benign, refractory esophageal strictures are an important therapeutic
challenge. Metal stents occasionally have been used, but results have been disappointing. The …
challenge. Metal stents occasionally have been used, but results have been disappointing. The …
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes
A Repici, R Pellicano, G Strangio… - Diseases of the colon …, 2009 - journals.lww.com
Open access endoscopy and screening programs enable detection and removal of an
increased number of colon polyps in the early stages of neoplastic transformation. Unfortunately, …
increased number of colon polyps in the early stages of neoplastic transformation. Unfortunately, …
Helicobacter species and liver diseases: association or causation?
R Pellicano, A Ménard, M Rizzetto… - The Lancet Infectious …, 2008 - thelancet.com
The discovery of Helicobacter hepaticus as a causal agent of hepatitis and hepatocarcinoma
in mice has stimulated interest in looking for Helicobacter spp in human liver samples. …
in mice has stimulated interest in looking for Helicobacter spp in human liver samples. …
A 2016 panorama of Helicobacter pylori infection: key messages for clinicians.
A comment on this article appears in" Which first-line treatment in Piedmont in the year 2017?"
Panminerva Med. 2017 Jun; 59 (2): 197. A comment on this article appears in" Vaccine as …
Panminerva Med. 2017 Jun; 59 (2): 197. A comment on this article appears in" Vaccine as …
[HTML][HTML] Infections with Helicobacter pylori and challenges encountered in Africa
Helicobacter pylori (H. pylori) is the causative agent of gastritis, peptic ulcer disease, mucosa
associated lymphoid tissue lymphoma and gastric cancer (GC). While this bacterium infects …
associated lymphoid tissue lymphoma and gastric cancer (GC). While this bacterium infects …
[HTML][HTML] Extra-esophageal presentation of gastroesophageal reflux disease: 2020 update
…, F Barutta, G Beccuti, G Gruden, R Pellicano - Journal of clinical …, 2020 - mdpi.com
Gastroesophageal reflux disease (GERD) is defined by the presence of symptoms induced
by the reflux of the stomach contents into the esophagus. Although clinical manifestations of …
by the reflux of the stomach contents into the esophagus. Although clinical manifestations of …
[HTML][HTML] History of inflammatory bowel diseases
GC Actis, R Pellicano, S Fagoonee… - Journal of clinical …, 2019 - mdpi.com
Inflammatory bowel diseases (IBD) are characterized by chronic inflammation of the intestinal
mucosa and unknown etiology. In this review, we identified three main eras in the IBD …
mucosa and unknown etiology. In this review, we identified three main eras in the IBD …
Helicobacters and extragastric diseases
R Pellicano, F Franceschi, G Saracco… - …, 2009 - Wiley Online Library
For two decades, Helicobacter pylori has been considered as the culprit in many extragastric
manifestations. However, for several of these supposed associations the hypothesis of an …
manifestations. However, for several of these supposed associations the hypothesis of an …
[HTML][HTML] Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma
R Pellicano, V Mazzaferro, WF Grigioni… - World Journal of …, 2004 - ncbi.nlm.nih.gov
AIM: Only a minority of patients carrying a defined viral aetiologic agent develop cirrhosis
and ultimately hepatocellular carcinoma (HCC), the mechanism underlying the worsening is …
and ultimately hepatocellular carcinoma (HCC), the mechanism underlying the worsening is …